ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 274 filers reported holding ALKERMES PLC in Q4 2022. The put-call ratio across all filers is 2.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,517,302 | -4.4% | 54,170 | +6.9% | 0.08% | -1.2% |
| Q2 2023 | $1,586,503 | +13.4% | 50,687 | +2.1% | 0.08% | -1.2% |
| Q1 2023 | $1,399,154 | +141.0% | 49,633 | +123.4% | 0.09% | +126.3% |
| Q4 2022 | $580,504 | +19.4% | 22,216 | +2.0% | 0.04% | +8.6% |
| Q3 2022 | $486,000 | -26.4% | 21,779 | -1.7% | 0.04% | -16.7% |
| Q2 2022 | $660,000 | +0.8% | 22,147 | -11.0% | 0.04% | +50.0% |
| Q1 2022 | $655,000 | +1.9% | 24,888 | -10.0% | 0.03% | +33.3% |
| Q4 2021 | $643,000 | -32.5% | 27,661 | -10.4% | 0.02% | -34.4% |
| Q3 2021 | $952,000 | +21.0% | 30,855 | -3.9% | 0.03% | +23.1% |
| Q2 2021 | $787,000 | +50.2% | 32,095 | +14.4% | 0.03% | +30.0% |
| Q1 2021 | $524,000 | -19.0% | 28,052 | -13.5% | 0.02% | -28.6% |
| Q4 2020 | $647,000 | +32.0% | 32,428 | +9.7% | 0.03% | +12.0% |
| Q3 2020 | $490,000 | -28.3% | 29,561 | -16.0% | 0.02% | -34.2% |
| Q2 2020 | $683,000 | +60.0% | 35,180 | +18.9% | 0.04% | +18.8% |
| Q1 2020 | $427,000 | -48.2% | 29,591 | -26.7% | 0.03% | -11.1% |
| Q4 2019 | $824,000 | +16.9% | 40,394 | +11.7% | 0.04% | 0.0% |
| Q3 2019 | $705,000 | -19.1% | 36,160 | -6.4% | 0.04% | -12.2% |
| Q2 2019 | $871,000 | -45.1% | 38,650 | -11.1% | 0.04% | -46.1% |
| Q1 2019 | $1,586,000 | +26.0% | 43,477 | +1.9% | 0.08% | -2.6% |
| Q4 2018 | $1,259,000 | -44.1% | 42,674 | -19.6% | 0.08% | -8.2% |
| Q3 2018 | $2,253,000 | +13.7% | 53,077 | +10.2% | 0.08% | +7.6% |
| Q2 2018 | $1,982,000 | -34.0% | 48,161 | -7.0% | 0.08% | -34.2% |
| Q1 2018 | $3,003,000 | -2.7% | 51,813 | -8.1% | 0.12% | +0.8% |
| Q4 2017 | $3,087,000 | -4.5% | 56,398 | -11.3% | 0.12% | -11.9% |
| Q3 2017 | $3,234,000 | -4.4% | 63,616 | +9.0% | 0.14% | -11.8% |
| Q2 2017 | $3,383,000 | -7.1% | 58,355 | -6.2% | 0.15% | -6.1% |
| Q1 2017 | $3,640,000 | -2.4% | 62,216 | -7.3% | 0.16% | -5.2% |
| Q4 2016 | $3,730,000 | +2.2% | 67,119 | -13.5% | 0.17% | -1.1% |
| Q3 2016 | $3,650,000 | +3.6% | 77,617 | -4.7% | 0.17% | +1.8% |
| Q2 2016 | $3,522,000 | +21.1% | 81,480 | -4.2% | 0.17% | +13.2% |
| Q1 2016 | $2,909,000 | -65.2% | 85,077 | -19.2% | 0.15% | -62.0% |
| Q4 2015 | $8,358,000 | +34.7% | 105,287 | -0.5% | 0.40% | +12.1% |
| Q3 2015 | $6,207,000 | -13.1% | 105,800 | -4.7% | 0.35% | +19.6% |
| Q2 2015 | $7,140,000 | +5.1% | 110,976 | -0.4% | 0.30% | +12.1% |
| Q1 2015 | $6,792,000 | +12.5% | 111,400 | +8.0% | 0.26% | +6.9% |
| Q4 2014 | $6,040,000 | +53.0% | 103,141 | +12.0% | 0.25% | +33.5% |
| Q3 2014 | $3,947,000 | -8.2% | 92,066 | +7.8% | 0.18% | -2.1% |
| Q2 2014 | $4,299,000 | -9.8% | 85,410 | -21.0% | 0.19% | -12.9% |
| Q1 2014 | $4,768,000 | +41.7% | 108,144 | +30.7% | 0.22% | +43.7% |
| Q4 2013 | $3,364,000 | +1219.2% | 82,723 | +991.3% | 0.15% | +978.6% |
| Q3 2013 | $255,000 | +20.9% | 7,580 | +3.1% | 0.01% | -6.7% |
| Q2 2013 | $211,000 | – | 7,352 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |